HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Five-year efficacy of finasteride in 801 Japanese men with androgenetic alopecia.

Abstract
Finasteride is standard medical treatment for androgenetic alopecia; however, no large studies with 5 years or more of follow up have been performed in Japan. The authors followed Japanese men with androgenetic alopecia treated with finasteride for 5 years to evaluate long-term treatment efficacy. Of 903 men treated with finasteride (1 mg/day), 801 patients were evaluated over 5 years by modified global photographic assessment. Although the proportion of improvement was high (99.4%), modified global photographic assessment scores after 5 years of treatment were lower in patients with more advanced disease as measured by the modified Norwood-Hamilton scale. After separating patients into "sufficient" and "insufficient" efficacy groups according to the modified global photographic assessment score after 5 years (scores ≥6 and <6, respectively), multivariate analysis showed that independent risk factors of insufficient efficacy were age at start of treatment of 40 years or more (P = 0.021) and classification on the modified Norwood-Hamilton scale (P < 0.001), whereas presence of stress at start of treatment was a negative predictor (P = 0.025). In conclusion, continuous finasteride treatment for 5 years improved androgenetic alopecia with sustained effect among Japanese. Younger age and less advanced disease at start of treatment were the key predictors of higher finasteride efficacy.
AuthorsToshihiro Yoshitake, Akira Takeda, Kensaku Ohki, Yuko Inoue, Takanori Yamawaki, Saori Otsuka, Minekatsu Akimoto, Mitsuru Nemoto, Yasuhito Shimakura, Akio Sato
JournalThe Journal of dermatology (J Dermatol) Vol. 42 Issue 7 Pg. 735-8 (Jul 2015) ISSN: 1346-8138 [Electronic] England
PMID25903108 (Publication Type: Journal Article)
Copyright© 2015 Japanese Dermatological Association.
Chemical References
  • 5-alpha Reductase Inhibitors
  • Finasteride
Topics
  • 5-alpha Reductase Inhibitors (therapeutic use)
  • Adult
  • Age Factors
  • Alopecia (drug therapy)
  • Finasteride (therapeutic use)
  • Humans
  • Japan
  • Male
  • Middle Aged
  • ROC Curve
  • Severity of Illness Index
  • Stress, Psychological (complications)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: